
Human CMV pp65 115-128, ALPLKMLNIPSINVH
Description
About Human CMV pp65 115-128, ALPLKMLNIPSINVH
The Human Cytomegalovirus (HCMV) (strain AD169) 65 kDa phosphoprotein (pp65) Peptide (IEDB: 149258) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The 65 kDa phosphoprotein (pp65) Peptide, H-ALPLKMLNIPSINVH-OH (Uniprot: P06725 aa: 115-128) from JPT is produced under strict quality control and quality management.
Human CMV pp65 115-128, ALPLKMLNIPSINVH - Specifications
- Peptide sequence: H-ALPLKMLNIPSINVH-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human CMV pp65 115-128, ALPLKMLNIPSINVH
References:
Read References with JPT’s Antigen Peptides
Human CMV pp65 115-128, ALPLKMLNIPSINVH has been described in:
Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation., J Immunother, 2011 (PMID: 21389867)
Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8<sup>+</sup> T memory cells in convalescent COVID-19 donors., Clin Transl Immunology, 2022 (PMID: 36254196)
Documentation
Documentation for Human CMV pp65 115-128, ALPLKMLNIPSINVH
Properties
Properties of Human CMV pp65 115-128, ALPLKMLNIPSINVH
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Human Cytomegalovirus (HCMV) |
Protein Name: | 65 kDa phosphoprotein (pp65) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human CMV pp65 115-128, ALPLKMLNIPSINVH
Information | Values |
---|---|
Sequence: | H-ALPLKMLNIPSINVH-OH |
Specifications: | 15mer peptide as TFA salt |